We all love a growing dividend and one of the most popular indices that cover the best dividend growth stocks is the S&P 500 Dividend Aristocrats index.
The index has currently 54 constituents. My goal in this article is to show you the currently cheapest stocks from the Dividend Aristocrats Index with current buy or better ratings.
I know, it�� a little bit easy to trust others work but the high-quality dividend stocks are already discovered. The only thing we must do is to screen the current valuations and market opinions.
Only twelve stocks fulfilled both, a forward P/E below 15 combined with a buy or better rating by brokerage firms. Half of the results have a projected double-digit mid-term earnings growth forecast.
I really like Dividend Aristocrats but because of the highly predictable business model and well known asset class, most of them are no longer cheap. Only eighteen stocks have an expected P/E under 15! That�� only one third of the full database and only around 20 percent of all Aristocrats are recommended to buy.
Top Managed Healthcare Stocks To Invest In Right Now: Cytec Industries Inc (CYT)
Cytec Industries Inc/De/, formerly Cytec Industries Inc., incorporated on December 17, 1993, is a specialty chemicals and materials company focused on developing, manufacturing and selling value-added products. Its products serve a diverse range of end markets, including aerospace and industrial materials, mining and plastics. The Company has four business segments: Engineered Materials, Umeco, In-Process Separation and Additive Technologies. Engineered Materials segment principally includes advanced composites, carbon fiber, and structural film adhesives. The Umeco segment includes composite and process materials, primarily for the aerospace and defense, wind energy, automotive, recreation and other industrial segments. The In Process Separation segment includes mining chemicals and phosphines. The Additive Technologies segment includes polymer additives, specialty additives and formulated resins. On July 20, 2012, the Company acquired Umeco plc.
Engineered Materials
The Engineered Materials segment is a global provider of technologically advanced materials for aerospace, high-performance industrial and other extreme-demand markets. Its primary product lines are advanced aerospace composites and structural adhesives, High performance industrial materials and Carbon fibers. Its major products in the advanced aerospace composites include aerospace- qualified prepregs, resin infusion systems and structural/surfacing adhesives. Its principal applications include commercial airliners, regional and business jets, military aircraft, including rotorcraft, satellites and launch vehicles. The products in the high performance industrial materials include Industrial-grade prepregs, resin infusion systems and structural/surfacing adhesives. Its applications include high performance automotive, defense, tooling and alternative energy. The products in carbon fibers include high performance fiber carbon fibers. Its applications include reinforcements for advanced aerospace and industrial c! omposites.
The Company is a supplier to the F-35 Joint Strike Fighter and F-18 fighter jet programs. It is also a supplier for the business and regional jet market, supporting programs, such as Bombardier�� CSeries and LearJet85. It also manufactures specialty adhesive forms for complex composites assemblies, such as honeycomb and sandwich structures and special surfacing films to provide aircraft lightning strike protection. It manufactures and sells various high-performance grades of both polyacrylonitrile (PAN) type and pitch type carbon fibers used as a reinforcement material for aerospace and other extreme-demand and high-performance composites.
The Company�� High Performance Industrial Materials (HPIM) product line strategy is to leverage its composites, adhesives and resin technologies across multiple industrial markets. The Company supplies composites and adhesives to a spectrum of markets, such as high performance and luxury low-rate serial automotive, defense, and alternative energy.
Umeco
Umeco�� primary product lines are High performance composites structural materials/solutions and Composite process materials/solutions. Its major products in the High performance composites structural materials/solutions include Aerospace-qualified prepregs, Industrial-grade prepreg. Its principal applications include large commercial airliners, military aircraft, high performance automotive, defense, tooling, recreation, industrial and alternative energy. The products in Composite process materials/solutions include Process materials/solutions including vacuum bagging, release films and sealant tapes. Its principal applications include large commercial airliners, military aircraft, high performance automotive, defense, tooling, recreation, industrial and alternative energy and Process materials for the forming, infusion, curing of composite structures.
The Company�� structural materials product line includes the development, manufa! cturing a! nd supply of advanced composite materials. It specializes in the manufacture of composite materials for a range of industries such as aerospace and defense, marine, motor sport and automotive, construction, wind energy, and recreation.
In-Process Separation
The In-Process Separation segment includes mining chemicals and phosphines. The Company�� mining chemicals product line include flotation promoters, collectors, frothers, dispersants and depressants, solvent extractants, flocculants, filter and dewatering aids, antiscalants, and defoamers . Its principal applications include mineral separation and processing for copper, alumina, cobalt, nickel, and other minerals. Its Phosphines include flame retardants, catalyst ligands, high purity phosphine gas and biocides.
Its phospine based specialty products are used primarily in the pharmaceutical, chemical and electronic manufacturing, and fumigation. Its patented MaxHT antiscalant is sold for suppressing sodalite scale formation. Its phosphine specialties are utilized for a variety of applications. It is a supplier of ultra- high purity phosphine gas, used in semiconductor manufacturing and light emitting diode applications, various phosphine derivative products, including phosphonium salts used in pharmaceutical catalysts and biocides. Included in the phosphine line are organo phosphorus compounds. The compounds are used primarily as intermediates and catalyst ligands for organic and chemical synthesis in the pharmaceutical and chemical industries.
Additive Technologies
The Additive Technologies segment includes polymer additives specialty additives and Formulated resins. Polymer additives include ultraviolet light stabilizers and absorbers, high performance antioxidants and antistatic agents. Its applications include plastics, coatings, and fibers for: agricultural films, automotive parts, architectural lighting, housewares, packaging, outdoor furniture, sporting goods, toys and apparel.! Specialt! y additives include surfactants, specialty monomers, resin amines, and PTZ Phenothiazine. Its Formulated resins are used in for bonding or sealing of electrical and electronic components.
The Company markets its Additive Technologies chemicals through specialized sales and technical service staffs for each of its product lines. Sales are usually made directly to customers and through distributors to smaller customers. The Company is a global supplier to the plastics industry of specialty additives, which protect plastics from the ultraviolet radiation of sunlight and from oxidation. It is a global supplier of sulfosuccinate surfactants, Docusate sodium, and PTZ phenothiazine. Sulfosuccinate surfactants and acrylamide-based specialty monomers products are used in emulsion polymers, paints, paper coatings, printing inks, and other diverse customer applications. Docusate is a pharmaceutical grade product used as both an active ingredient and excipient/formulating aid. PTZ phenothiazine is primarily used as an acrylic acid, acrylic ester and methacrylate monomer stabilizer.
Advisors' Opinion:- [By alicet236]
Vice President and CFO of Cytec Industries Inc. (CYT) David Drillock sold 49,038 shares on July 21 at an average price of $107.06. The total transaction amount was $5,250,008.
- [By Stoyan Bojinov]
The New Jersey-based specialty chemicals maker, Cytec Industries (CYT), announced third quarter operating results after the closing bell on Thursday that topped analysts’ estimates.
Cytec Industries managed to rake in revenues of $464 million last quarter, falling short of the projected $482.61 million figure. The company did manage to beat the mark, however, in terms of earnings per share; in the third quarter Cytec generated EPS of $1.32, beating the expected EPS of $1.34 by two pennies.
Looking back, the most recent quarterly results are well above the 91 cents EPS seen in Q3 exactly one year ago. Looking ahead, the company expects FY2013 EPS of $4.70-$4.80 compared to the consensus of $4.82.
Cytec Industries shares rallied higher on Thursday, gaining 0.58% on the day. The stock is up 25% YTD.
Best Cheapest Stocks To Invest In Right Now: Life Technologies Corporation(LIFE)
Life Technologies Corporation operates as a global life sciences company. The company?s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company?s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporat ion also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. The company was founded in 1987 and is headquartered in Carlsbad, California.
Advisors' Opinion:- [By Rich Smith]
The Wall Street Journal calls Carlsbad, Calif.-based Life Technologies (NASDAQ: LIFE ) an $11 billion "company you never heard of." As the Journal reports, a buyout group including private-equity powerhouses Blackstone (NYSE: BX ) , Carlyle Group (NASDAQ: CG ) , and KKR (NYSE: KKR ) is putting together an $11 billion bid to acquire the lab research equipment manufacturer. But as it turns out, Life is doing a bit of acquiring itself.
Best Cheapest Stocks To Invest In Right Now: Worthington Industries Inc.(WOR)
Worthington Industries, Inc. operates as a diversified metals processing company focusing on steel processing and manufactured metal products in the United States, Canada, and Europe. It processes flat-rolled steel and stainless steel for the automotive, construction, lawn and garden, hardware, furniture, office equipment, electrical control, tubing, leisure and recreation, appliance, agricultural, HVAC, container, and aerospace markets. The company also produces low-pressure liquefied petroleum gas and refrigerant gas cylinders; high-pressure and industrial/specialty gas cylinders; seamless steel high pressure cylinders for compressed natural gas storage in motor vehicles; aluminum-lined, composite-wrapped high-pressure cylinders; airbrake tanks; and consumer products. In addition, it produces recovery tanks for refrigerant gases; air reservoirs for truck and trailer original equipment manufacturers; and Balloon Time helium kits. Further, the company designs and manufactu res reusable custom platforms, racks, and pallets made of steel for supporting, protecting, and handling products throughout the shipping process; provides framing systems and stairs for mid-rise buildings, and current and past model automotive service stampings; designs, builds, and supplies light gauge steel framed commercial structures and multi-family housing units; supplies and constructs metal framing products for single family housing with a focus on military housing; and manufactures pre-engineered steel egress stair solutions. Worthington Industries was founded in 1955 and is headquartered in Columbus, Ohio.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Harsco have gained 4.7% to $26.43 today at 1:16 p.m., outpacing other construction & engineering companies. Dycom (DY) has advanced 0.5% to $30, KBR Inc. (KBR) has ticked up 0.1% to $33.03, Worthington Industries�(WOR) has risen 2.8% to $38.85�and Tutor Perini (TPC) has rallied 3.6% to $22.46.
Best Cheapest Stocks To Invest In Right Now: Spdr S&P Pharmaceuticals Etf (XPH)
SPDR S&P Pharmaceuticals Exchange Traded Fund (The Fund) seeks to replicate as closely as possible, before expenses, the performance of an index derived from the pharmaceuticals segment of a United States total market composite index. The Fund uses a passive management strategy designed to track the total return performance of the S&P Pharmaceuticals Select Industry Index (the Pharmaceuticals Index).
The Pharmaceuticals Index represents the pharmaceuticals sub-industry portion of the S&P TMI. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange (NYSE), American Stock Exchange (AMEX), National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Advisors' Opinion:- [By Selena Maranjian]
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some pharmaceutical stocks to your portfolio, the SPDR S&P Pharmaceuticals ETF (NYSEMKT: XPH ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
The basics
ETFs often sport lower expense ratios than their mutual fund cousins. The SPDR ETF's expense ratio -- its annual fee -- is a relatively low 0.35%.
This ETF has trounced the world markets over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.
Best Cheapest Stocks To Invest In Right Now: Redrow PLC (RDW)
Redrow PLC is a United Kingdom-based company engaged in residential development, which includes mixed use development. The Company�� operations are primarily focused on house building. Its completed projects include Signature, In the City/Regeneration and Debut. The Company's land holdings consist of both a current and forward land bank. As of June 30, 2010, the current land bank consisted of 11,600 plots owned with planning and 1,570 contracted plots, and its forward lank bank stood at around 22,000 plots. Its subsidiaries include Redrow Homes (Scotland) Ltd, Redrow Homes (Yorkshire) Ltd, Redrow Homes (Lancashire) Ltd, Redrow plc & Redrow Homes (NW) Ltd, Redrow Homes (Midlands) Ltd, Redrow Homes (South Midlands) Ltd, Redrow Homes (South West) Ltd, Redrow Homes (South Wales) Ltd and Redrow Homes (Eastern) Ltd. Advisors' Opinion:- [By Namitha Jagadeesh]
Redrow Plc (RDW) rallied 3.2 percent to 245.6 pence as Deutsche Bank AG increased its 12-month share-price estimate and profit forecasts for 2013 and 2014. The U.K. builder yesterday jumped the most in five months after saying pretax profit for the year ended June will beat analysts��estimates.
Best Cheapest Stocks To Invest In Right Now: Transcept Pharmaceuticals Inc.(TSPT)
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its principal product is the Intermezzo, a low dose sublingual formulation of zolpidem as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has a collaboration agreement with Purdue Pharmaceutical Products, L.P. for the commercialization of Intermezzo in the United States. It is also developing TO-2061, a low dose ondansetron adjunctive therapy, which is in Phase II study for patients with obsessive-compulsive disorder. The company was founded in 2002 and is based in Point Richmond, California.
Advisors' Opinion:- [By Roberto Pedone]
Transcept Pharmaceuticals (TSPT) is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. This stock closed up 6% to $2.98 in Thursday's trading session.
Thursday's Range: $2.81-$2.99
52-Week Range: $2.77-$6.77
Thursday's Volume: 138,000
Three-Month Average Volume: 158,095From a technical perspective, TSPT spiked sharply higher here right above some near-term support at $2.77 and back above its 50-day moving average at $2.95 with decent upside volume. This move is quickly pushing shares of TSPT within range of triggering a major breakout trade. That trade will hit if TSPT manages to take out some near-term overhead resistance levels at $3.16 to $3.25 with high volume. If that breakout hits, it would also push TSPT outside of a large consolidation pattern the stock has been in for the last three months.
Traders should now look for long-biased trades in TSPT as long as it's trending above some key near-term support at $2.77 and then once it sustains a move or close above those breakout levels with volume that hits near or above 158,095 shares. If that breakout triggers soon, then TSPT will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to its 200-day moving average at $4.50. Any high-volume move above those levels will then put $4.89 to $5 into range for shares of TSPT.
- [By Roberto Pedone]
An under-$10 biotech stock that's trending very close to triggering a near-term breakout trade is Transcept Pharmaceuticals (TSPT), which is focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. This stock has been hit hard by the bears so far in 2013, with shares off by 36%.
If you take a look at the chart for TSPT, you'll notice that this stock has been trending sideways inside of a big consolidation pattern for the last three months, with shares moving between $2.71 on the downside and $3.25 on the upside. Shares of TSPT are counter-trending higher today in the face of a very weak tape. This move is starting to push the stock within range of triggering a near-term breakout trade above the upper-end of its sideways trading chart pattern.
Traders should now look for long-biased trades in TSPT if it manages to break out above its 50-day moving average at $2.91 a share and then once it takes out more near-term overhead resistance levels at $3.16 to $3.25 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 138,444 shares. If that breakout triggers soon, then TSPT will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to its 200-day at $4.39 a share. If those levels get taken out with volume, then TSPT could easily hit its next major overhead resistance levels at $5 to $5.50 a share.
Traders can look to buy TSPT off weakness to anticipate that breakout and simply use a stop that sits right below its recent low of $2.71 a share. One can also buy TSPT off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Best Cheapest Stocks To Invest In Right Now: Essex Property Trust Inc. (ESS)
Essex Property Trust, Inc. operates as a self-administered and self-managed real estate investment trust in the United States. It engages in the ownership, operation, management, acquisition, development, and redevelopment of apartment communities, as well as commercial properties. As of March 31, 2012, the company owned or had interests in 158 apartment communities; and 5 commercial buildings, as well as 5 development projects. Its communities are located in Los Angeles, Orange, Riverside, San Diego, Santa Barbara, and Ventura counties in southern California; and the San Francisco Bay area in northern California, as well as in the Seattle metropolitan area. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. Essex Property Trust, Inc. was founded in 1971 and is headquartered in Palo Alto, California.
Advisors' Opinion:- [By Jayson Derrick]
Owners of BRE Properties (NYSE: BRE) will receive $12.33 in cash and 0.2971 shares of newly created Essex common stock following Essex Property Trust's (NYSE: ESS) acquisition. Shares of Essex lost 3.31 percent, closing at $142.81.
- [By Jayson Derrick]
Bloomberg reported�Essex Property Trust Inc. (NYSE: ESS) has made an offer to acquire BRE Properties for about $5 billion.
BRE Properties Chief Executive Office Constance B. Moore had publicly hinted earlier this year that the company would consider ��ny legitimate proposal��after an investment firm Land & Buildings had made a $4.6 billion offer valued at $60 a share.
- [By Susan J. Aluise]
Like all ETFs, REZ offers the diversification of a mutual fund, with low expenses and the advantages of trading on a major exchange just like a stock. REZ�� top holdings include multifamily REITs like AvalonBay (AVB), Equity Residential (EQR), Essex Property Trust (ESS) as well as Public Storage (PSA) common stock, which also benefits from the rental housing boom.
No comments:
Post a Comment